Literature DB >> 7825594

Genetic testing and insurance. The Ad Hoc Committee on Genetic Testing/Insurance Issues.

.   

Abstract

The rapid expansion of opportunities for genetic testing has been accompanied by complex questions about the appropriate relationships between providers, patients, and insurers. Some of these questions involve large public-policy decisions, such as whether the government should guarantee access to health care for all citizens. Universal access to health care, without regard to past, present, or future risk of disease, could eliminate risk-oriented underwriting in health-care coverage. A positive response to that question will ameliorate other problems. Until universal access is reality, genetic testing and genetic diagnosis will raise important issues for the practicing geneticist. How much does a client need to know about insurance implications before consenting to a genetic test? Should patients be counseled to purchase insurance before being tested? Should genetic information be excluded from medical records before their release to insurance companies for routine reimbursements or underwriting? What are the ethical and legal responsibilities of the geneticist?

Entities:  

Keywords:  American Society of Human Genetics; Genetics and Reproduction; Health Care and Public Health

Mesh:

Year:  1995        PMID: 7825594      PMCID: PMC1801295     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  8 in total

1.  Insurance for the insurers. The use of genetic tests.

Authors:  N E Kass
Journal:  Hastings Cent Rep       Date:  1992 Nov-Dec       Impact factor: 2.683

2.  Genetic discrimination and insurance underwriting.

Authors:  J A Lowden
Journal:  Am J Hum Genet       Date:  1992-10       Impact factor: 11.025

3.  Eugenics and genetic discrimination.

Authors:  N A Holtzman; M A Rothstein
Journal:  Am J Hum Genet       Date:  1992-03       Impact factor: 11.025

4.  Discrimination as a consequence of genetic testing.

Authors:  P R Billings; M A Kohn; M de Cuevas; J Beckwith; J S Alper; M R Natowicz
Journal:  Am J Hum Genet       Date:  1992-03       Impact factor: 11.025

5.  Use of genetic information by private insurers. Genetic advances: the perspective of an insurance medical director.

Authors:  R J Pokorski
Journal:  J Insur Med       Date:  1992

6.  Genetics and the moral mission of health insurance.

Authors:  T H Murray
Journal:  Hastings Cent Rep       Date:  1992 Nov-Dec       Impact factor: 2.683

7.  Insurance and genetic testing: where are we now?

Authors:  H Ostrer; W Allen; L A Crandall; R E Moseley; M A Dewar; D Nye; S V McCrary
Journal:  Am J Hum Genet       Date:  1993-03       Impact factor: 11.025

8.  Legal aspects of genetic information.

Authors:  L B Andrews
Journal:  Yale J Biol Med       Date:  1991 Jan-Feb
  8 in total
  6 in total

1.  Medical genetics: 3. An approach to the adult with a genetic disorder.

Authors:  Dawna M Gilchrist
Journal:  CMAJ       Date:  2002-10-29       Impact factor: 8.262

2.  The wide variation of definitions of genetic testing in international recommendations, guidelines and reports.

Authors:  Jorge Sequeiros; Milena Paneque; Bárbara Guimarães; Elina Rantanen; Poupak Javaher; Irma Nippert; Jörg Schmidtke; Helena Kääriäainen; Ulf Kristoffersson; Jean-Jacques Cassiman
Journal:  J Community Genet       Date:  2012-02-25

3.  Attitudes of physicians regarding receiving and storing patients' genetic testing results for cancer susceptibility.

Authors:  L M Wasserman; O W Jones; J S Trombold; G R Sadler
Journal:  J Community Health       Date:  2000-08

4.  Bio-Repository of DNA in stroke (BRAINS): a study protocol.

Authors:  Sunaina Yadav; Renata Schanz; Ankita Maheshwari; Muhammad Saleem Khan; Julia Slark; Ranil de Silva; Paul Bentley; Philippe Froguel; Jaspal Kooner; Padma Shrivastav; Kameshwar Prasad; Pankaj Sharma
Journal:  BMC Med Genet       Date:  2011-03-02       Impact factor: 2.103

5.  The Siblings With Ischemic Stroke Study (SWISS) protocol.

Authors:  James F Meschia; Robert D Brown; Thomas G Brott; Felix E Chukwudelunzu; John Hardy; Stephen S Rich
Journal:  BMC Med Genet       Date:  2002-02-12       Impact factor: 2.103

6.  The Ischemic Stroke Genetics Study (ISGS) Protocol.

Authors:  James F Meschia; Thomas G Brott; Robert D Brown; Richard J P Crook; Michael Frankel; John Hardy; José G Merino; Stephen S Rich; Scott Silliman; Bradford Burke Worrall
Journal:  BMC Neurol       Date:  2003-07-08       Impact factor: 2.474

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.